Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

990 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia.
Motohashi K, Fujisawa S, Doki N, Kobayashi T, Mori T, Usuki K, Tanaka M, Fujiwara S, Kako S, Aoyama Y, Onoda M, Yano S, Gotoh M, Kanamori H, Takahashi S, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Motohashi K, et al. Among authors: aoyama y. Leuk Lymphoma. 2018 Jun;59(6):1332-1337. doi: 10.1080/10428194.2017.1387913. Epub 2017 Oct 16. Leuk Lymphoma. 2018. PMID: 29032731
A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort.
Ohwada C, Sakaida E, Igarashi A, Kobayashi T, Doki N, Mori T, Kato J, Koda Y, Kanamori H, Tanaka M, Tachibana T, Fujisawa S, Nakajima Y, Numata A, Toyosaki M, Aoyama Y, Onizuka M, Hagihara M, Koyama S, Kanda Y, Nakasone H, Shimizu H, Kato S, Watanabe R, Shono K, Sakai R, Saito T, Nakaseko C, Okamoto S. Ohwada C, et al. Among authors: aoyama y. Biol Blood Marrow Transplant. 2020 Jan;26(1):162-170. doi: 10.1016/j.bbmt.2019.09.016. Epub 2019 Sep 16. Biol Blood Marrow Transplant. 2020. PMID: 31536824 Free article. Clinical Trial.
Association between measurable residual disease kinetics and outcomes of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Hara R, Onizuka M, Kikkawa E, Shiraiwa S, Harada K, Aoyama Y, Ogiya D, Toyosaki M, Suzuki R, Machida S, Ohmachi K, Ogawa Y, Kawada H, Matsushita H, Ando K. Hara R, et al. Among authors: aoyama y. Ann Hematol. 2021 Oct;100(10):2479-2486. doi: 10.1007/s00277-021-04587-9. Epub 2021 Jul 11. Ann Hematol. 2021. PMID: 34247299
Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection.
Shiraiwa S, Harada K, Onizuka M, Kawakami S, Hara R, Aoyama Y, Amaki J, Ogiya D, Suzuki R, Toyosaki M, Machida S, Omachi K, Kawada H, Ogawa Y, Ando K. Shiraiwa S, et al. Among authors: aoyama y. J Infect Chemother. 2022 Sep;28(9):1279-1285. doi: 10.1016/j.jiac.2022.05.014. Epub 2022 Jun 10. J Infect Chemother. 2022. PMID: 35691863
Association of CDKN2A/2B deletion with relapse after hematopoietic stem cell transplantation for acute lymphoblastic leukemia.
Onizuka M, Kikkawa E, Machida S, Toyosaki M, Suzuki R, Ogiya D, Aoyama Y, Amaki J, Harada K, Hara R, Shiraiwa S, Ogawa Y, Kawada H, Ando K. Onizuka M, et al. Among authors: aoyama y. Blood Cell Ther. 2023 Jul 21;6(3):80-86. doi: 10.31547/bct-2023-004. eCollection 2023 Aug 25. Blood Cell Ther. 2023. PMID: 38146355 Free PMC article.
Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis.
Toya T, Mizuno K, Sakurai M, Kato J, Mori T, Doki N, Masuda S, Aotsuka N, Tsukamoto S, Sakaida E, Nakajima Y, Fujisawa S, Machida S, Aoyama Y, Yokoyama H, Shono K, Hatta Y, Usuki K, Kataoka K, Kanda Y. Toya T, et al. Among authors: aoyama y. Blood Adv. 2024 Mar 12;8(5):1084-1093. doi: 10.1182/bloodadvances.2023010735. Blood Adv. 2024. PMID: 38330190 Free PMC article.
990 results